| YKL202W |
Saccharomyces cerevisiae |
|
YKL202W is differentially expressed in 8 experiments [12 up/7 dn]: 4 compound treatments: none [1 up/1 dn], doxycycline [1 up/0 dn], ...; 2 genotypes: abf1-1 hypomorph / GAL-ABF1 overexpression transgene [1 up/0 dn], tetO2-PAF1-6HA [1 up/0 dn], 3 growth conditions, 2 material types, 2 strain or lines |
| YKL202W |
|
|
|
P36042
|
|
|
|
YKL202W
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Control
|
Growth condition |
|
|
Dessication
|
Growth condition |
|
|
Rehydration
|
Growth condition |
|
|
None
|
Compound treatment |
|
|
Polysomal_RNA
|
Material type |
|
|
Doxycycline
|
Compound treatment |
|
|
Sodium chloride
|
Compound treatment |
|
|
Commercial dry active yeast
|
Strain or line |
|
|
BY4743
|
Strain or line |
|
|
Methyl methanesulfonate
|
Compound treatment |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Total_RNA
|
Material type |
|
|
|
|
|
Processing time: 0.028 secs.